Ponatinib

Ponatinib is an orally available, multitargeted kinase inhibitor (IC50s: 0.37/1.1/1.5/2.2/5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively).

Price Not Available 200 mg Ponatinib Supplier Page

Catalog Number	T2372
Alternative Name(s)	AP24534
Research Area	Angiogenesis\|\|\|Autophagy\|\|\|Cytoskeletal Signaling\|\|\|Tyrosine Kinase/Adaptors
Molecular Formula	C29H27F3N6O
CAS#	943319-70-8
Purity	99.74%
SMILES	CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1
Size	200 mg
Supplier Page	https://www.targetmol.com/compound/Ponatinib
Additional Information	https://www.targetmol.com/datasheet/T2372